Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Toshihide, Izumida"'
Autor:
Toshihide Izumida, Teruhiko Imamura, Takatoshi Koi, Masaki Nakagaito, Hiroshi Onoda, Shuhei Tanaka, Ryuichi Ushijima, Naoya Kataoka, Makiko Nakamura, Mitsuo Sobajima, Nobuyuki Fukuda, Hiroshi Ueno, Koichiro Kinugawa
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1443-1451 (2024)
Abstract Aims Remote dielectric sensing (ReDS) represents a contemporary non‐invasive technique reliant on electromagnetic energy to quantify pulmonary congestion. Its prognostic significance within the context of heart failure (HF) patients remain
Externí odkaz:
https://doaj.org/article/91a001acb96c42a99593c8a9ba903764
Publikováno v:
Journal of Epidemiology, Vol 32, Iss 3, Pp 145-150 (2022)
Background: Sleeping pills are widely used for sleep disorders and insomnia. This population-based study aimed to evaluate the association between the use of sleeping pills and metabolic syndrome (MetS) and metabolic components in an apparently healt
Externí odkaz:
https://doaj.org/article/4e340be8239d4a1d87481c494def9b60
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Cardiac amyloidosis usually presents with diastolic dysfunction, but sometimes systolic dysfunction develops, particularly at its advanced stage. However, the therapeutic strategy for patients with cardiac amyloidosis and systolic dysfunction remains
Externí odkaz:
https://doaj.org/article/9f25b1acaa3143d298f4b86801260ffd
Publikováno v:
Medicina, Vol 59, Iss 5, p 909 (2023)
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is a phenotype of pulmonary hypertension due to chronic and multiple organized thrombus. The therapeutic strategy for patients with CTEPH and comorbid protein S deficiency remains un
Externí odkaz:
https://doaj.org/article/63f61a90e022448797460e1a8111c785
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 3231-3234 (2020)
Abstract Aims Heart rate reduction therapy using ivabradine, a selective inhibitor of the funny current of the sinoatrial node, is widely used in the systolic heart failure cohort. However, the optimal target of heart rate remains controversial. The
Externí odkaz:
https://doaj.org/article/7b0fd7f4d2da4ae5b7d492d43a902df5
Publikováno v:
Medicina, Vol 59, Iss 2, p 401 (2023)
Combined cases of hypertrophic obstructive cardiomyopathy (HOCM) and pulmonary arterial hypertension (PAH) are rare and have a management dilemma. Although preload is crucial in the management of HOCM, anti-PAH agents dramatically change the preload,
Externí odkaz:
https://doaj.org/article/9f1f1b321f884be6bc4bf9758c2cd78f
Publikováno v:
BMJ Open, Vol 11, Iss 2 (2021)
Objectives Small dense low-density lipoprotein cholesterol (sdLDL-C) might be a better cardiovascular disease (CVD) indicator than low-density lipoprotein cholesterol (LDL-C); however, details regarding its epidemiology remain elusive. The present st
Externí odkaz:
https://doaj.org/article/ad29dd1a220b4328971f4b290347718e
Autor:
Toshihiro, Higashikawa, Tomohiko, Ito, Takurou, Mizuno, Keiichiro, Ishigami, Kengo, Kuroki, Naoto, Maekawa, Daisuke, Usuda, Toshihide, Izumida, Shinya, Yamada, Ryusho, Sangen, Kazu, Hamada, Jun, Kiyosawa, Atsushi, Saito, Masaharu, Iguchi, Yuji, Kasamaki, Takeshi, Nakahashi, Akihiro, Fukuda, Hitoshi, Saito, Tsugiyasu, Kanda, Masashi, Okuro
Publikováno v:
Acta Medica Okayama. 76(6):705-713
The sodium glucose transporter 2 (SGLT2) inhibitor tofogliflozin is a glucose-lowering drug that causes the excretion of surplus glucose by inhibiting SGLT2. Because of tofogliflozin’s osmotic diuresis mechanism, patients’ serum electrolytes, bod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c24086b5fe32d5a3f11e1d6574dbde5d
https://ousar.lib.okayama-u.ac.jp/64121
https://ousar.lib.okayama-u.ac.jp/64121
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 12, p 182 (2021)
Background: Optimal heart rate (HR) that associates with higher cardiac output and greater clinical outcomes in patients with cardiac amyloidosis remains unknown. Methods: Consecutive patients with sinus rhythm who were diagnosed with cardiac amyloid
Externí odkaz:
https://doaj.org/article/a486d5d3bca949758dc22eb142c729bb
Publikováno v:
International Heart Journal. 63:1128-1133
Plasma B-type natriuretic peptide (BNP) is a practical tool with which to estimate hemodynamic status including intra-cardiac pressure in patients with heart failure (HF). However, plasma BNP levels cannot be measured immediately in an outpatient pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b17c0c94a0ea2abf550d1073dfb2838
https://doi.org/10.1536/ihj.22-348
https://doi.org/10.1536/ihj.22-348